Amyloidogenic nanoplaques in cerebrospinal fluid: relationship to amyloid brain uptake and clinical Alzheimer’s disease in a memory clinic cohort

Manuscript Number: 


Mari Aksnes, Nenad Bogdanovic, Trine Holt Edwin, Anne-Brita Knapskog, Ebba Gløersen Müller, Mona-Elisabeth Revheim, Lars Terenius, Ann Tiiman, Vladana Vukojević


Mari Aksnes

  • Nothing to Disclose

Nenad Bogdanovic

  • Nothing to Disclose

Trine Holt Edwin

  • Patents/Royalties
    Dr. Edwin report work as a rater with Roche BN29553 and with Boehringer-Ingelheim 1346.0023, outside the submitted work. The salary was paid by Oslo University Hospital

Anne-Brita Knapskog

  • Patents/Royalties
    I have been principal investigator on clinical trials for Roche (BN29553) and Boehringer-Ingelheim (1346.0023) at our site.

Ebba Gløersen Müller

  • Nothing to Disclose

Mona-Elisabeth Revheim

  • Nothing to Disclose

Lars Terenius

  • Nothing to Disclose

Ann Tiiman

  • Equity:
    AmyloiDia AB

Vladana Vukojević

  • Equity:
    Co-founder of AmyloiDia Sweden AB, 14 % ownership.
    Methods patent applicaton.